Gadocoletic acid trisodium salt
Alternative Names: B22956/1Latest Information Update: 07 Sep 2015
At a glance
- Originator Bracco
- Class Gadolinium-containing contrast agents; Organometallic compounds
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Coronary artery disease
Most Recent Events
- 10 Apr 2007 Phase-II clinical trials in Coronary artery disease (diagnosis) in Italy (Injection)
- 25 Feb 2005 A preclinical study has been added to the Ischaemic heart disease pharmacodynamics section
- 05 Feb 2004 A clinical study has been added into adverse events, pharmacokinetics and Ischaemic heart disease pharmacodynamics sections